Intranasal GHRP-2 Effectively Stimulates Growth Hormone in Short-Stature Children
Intranasal GHRP-2 effectively stimulated GH release in children with short stature, offering a needle-free alternative to injectable GH therapy.
Quick Facts
What This Study Found
Intranasal GHRP-2 effectively stimulated GH release in children with short stature, demonstrating viability of a needle-free delivery route.
Key Numbers
How They Did This
Clinical trial administering intranasal GHRP-2 to children with short stature and measuring GH responses.
Why This Research Matters
For children who need GH therapy, a nasal spray could eliminate the need for daily injections — a major quality-of-life improvement for pediatric patients.
The Bigger Picture
Intranasal peptide delivery represents a major advance in pediatric endocrinology, potentially replacing painful daily injections with a simple nasal spray.
What This Study Doesn't Tell Us
Clinical trial; specific treatment outcomes, dosing, duration, and sample size not detailed in abstract. Long-term growth effects not assessed.
Questions This Raises
- ?Does intranasal GHRP-2 produce sufficient GH stimulation for long-term growth improvement?
- ?How does intranasal bioavailability compare to subcutaneous injection?
Trust & Context
- Key Stat:
- Needle-free GH stimulation Intranasal GHRP-2 effectively stimulated GH release in children, offering an alternative to daily injections
- Evidence Grade:
- Moderate clinical evidence from a pediatric trial. Demonstrates intranasal efficacy but long-term treatment effects not assessed.
- Study Age:
- Published in 1997, this study explored intranasal GHRP delivery that has since informed peptide nasal spray development.
- Original Title:
- Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
- Published In:
- The Journal of endocrinology, 155(1), 79-86 (1997)
- Authors:
- Pihoker, C, Badger, T M, Reynolds, G A, Bowers, C Y
- Database ID:
- RPEP-00422
Evidence Hierarchy
Frequently Asked Questions
Can GHRP-2 be taken as a nasal spray?
Yes. This study showed intranasal GHRP-2 effectively stimulates GH release in children. The nasal mucosa allows peptide absorption into the bloodstream without injection.
Why is this important for children?
Children with GH deficiency typically need daily injections, which are painful and stressful. A nasal spray that achieves the same GH stimulation could dramatically improve treatment compliance and quality of life.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00422APA
Pihoker, C; Badger, T M; Reynolds, G A; Bowers, C Y. (1997). Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.. The Journal of endocrinology, 155(1), 79-86.
MLA
Pihoker, C, et al. "Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.." The Journal of endocrinology, 1997.
RethinkPeptides
RethinkPeptides Research Database. "Treatment effects of intranasal growth hormone releasing pep..." RPEP-00422. Retrieved from https://rethinkpeptides.com/research/pihoker-1997-treatment-effects-of-intranasal
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.